STOCK TITAN
  1. Home
  2. Sec-filings
  3. XBIT
  4. [ARS] XBiotech Inc SEC Filing

[ARS] XBiotech Inc SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - XBiotech Inc

ARS Filing - XBiotech Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: XBiotech Inc (XBIT)

Acceptance Date: 2025-07-07T17:25:01.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock XBIT logo
Xbiotech

NASDAQ:XBIT

XBIT Rankings

#4831 Ranked by Market Cap
N/A Ranked by Dividends

XBIT Latest News

Dec 23, 2024
XBiotech Pauses Rheumatology program
Jun 18, 2024
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Jan 4, 2024
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
Nov 14, 2023
Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
Sep 26, 2023
XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

XBIT Latest SEC Filings

Sep 2, 2025
[8-K] XBiotech Inc Reports Material Event
Aug 13, 2025
[10-Q] XBiotech Inc Quarterly Earnings Report
Jul 7, 2025
[DEF 14A] XBiotech Inc Definitive Proxy Statement
Jun 24, 2025
[8-K] XBiotech Inc Reports Material Event

XBIT Stock Data

90.85M
19.32M
36.61%
11.4%
1.38%
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN